002864 盘龙药业
已收盘 07-31 15:00:00
资讯
新帖
简况
数十家机构扎堆调研！盘龙药业基药红利释放打开成长空间
中金财经 · 07-16
数十家机构扎堆调研！盘龙药业基药红利释放打开成长空间
盘龙药业（002864）披露2025年年度权益分派实施公告，7月15日股价上涨2.58%
证券之星 · 07-15
盘龙药业（002864）披露2025年年度权益分派实施公告，7月15日股价上涨2.58%
盘龙药业（002864）披露控股股东持股比例因回购注销被动增加触及1%及5%整数倍公告，7月14日股价上涨2.57%
证券之星 · 07-14
盘龙药业（002864）披露控股股东持股比例因回购注销被动增加触及1%及5%整数倍公告，7月14日股价上涨2.57%
盘龙药业：盘龙七片入选2026国家基药目录，凭硬核资质打开业绩增量空间
中金财经 · 07-10
盘龙药业：盘龙七片入选2026国家基药目录，凭硬核资质打开业绩增量空间
创新药概念震荡拉升，盘龙药业一度涨超9%
证券之星 · 06-23
创新药概念震荡拉升，盘龙药业一度涨超9%
盘龙药业：截至2026年一季度公司已完成509个中药配方颗粒品种备案
证券之星 · 06-04
盘龙药业：截至2026年一季度公司已完成509个中药配方颗粒品种备案
盘龙药业（002864）披露向2026年股票期权激励计划激励对象授予股票期权的公告，6月1日股价上涨1.91%
证券之星 · 06-01
盘龙药业（002864）披露向2026年股票期权激励计划激励对象授予股票期权的公告，6月1日股价上涨1.91%
盘龙药业（002864）披露2026年股票期权激励计划内幕信息知情人及激励对象买卖公司股票情况自查报告，5月27日股价下跌0.39%
证券之星 · 05-27
盘龙药业（002864）披露2026年股票期权激励计划内幕信息知情人及激励对象买卖公司股票情况自查报告，5月27日股价下跌0.39%
盘龙药业（002864）披露2026年股票期权激励计划（草案），5月13日股价上涨2.96%
证券之星 · 05-13
盘龙药业（002864）披露2026年股票期权激励计划（草案），5月13日股价上涨2.96%
盘龙药业（002864）披露召开2025年年度股东会的通知，5月6日股价上涨0.2%
证券之星 · 05-06
盘龙药业（002864）披露召开2025年年度股东会的通知，5月6日股价上涨0.2%
每周股票复盘：盘龙药业（002864）一季度净利降30.36%
证券之星 · 05-03
每周股票复盘：盘龙药业（002864）一季度净利降30.36%
盘龙药业（002864）披露2026年一季度报告，4月27日股价上涨0.46%
证券之星 · 04-27
盘龙药业（002864）披露2026年一季度报告，4月27日股价上涨0.46%
盘龙药业：坚持以高质量经营夯实基本面
证券之星 · 04-23
盘龙药业：坚持以高质量经营夯实基本面
盘龙药业：公司高度重视股东回报与价值维护
证券之星 · 04-02
盘龙药业：公司高度重视股东回报与价值维护
股市必读：盘龙药业（002864）3月23日收盘跌7.82%，主力净流入734.79万元
证券之星 · 03-24
股市必读：盘龙药业（002864）3月23日收盘跌7.82%，主力净流入734.79万元
盘龙药业：3月12日董事朱文锋减持股份合计2.25万股
证券之星 · 03-13
盘龙药业：3月12日董事朱文锋减持股份合计2.25万股
盘龙药业最新公告：获得硫酸氨基葡萄糖胶囊药品注册证书
证券之星 · 03-03
盘龙药业最新公告：获得硫酸氨基葡萄糖胶囊药品注册证书
股市必读：盘龙药业（002864）2月25日董秘有最新回复
证券之星 · 02-26
股市必读：盘龙药业（002864）2月25日董秘有最新回复
盘龙药业（002864）披露注销部分募集资金账户公告，2月5日股价上涨3.05%
证券之星 · 02-05
盘龙药业（002864）披露注销部分募集资金账户公告，2月5日股价上涨3.05%
盘龙药业（002864）披露董事减持股份预披露公告，2月3日股价上涨0.28%
证券之星 · 02-03
盘龙药业（002864）披露董事减持股份预披露公告，2月3日股价上涨0.28%
加载更多
公司概况
公司名称：
陕西盘龙药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2017-11-16
主营业务：
陕西盘龙药业集团股份有限公司的主营业务是药材规范化种植、药品生产、研发、销售和医药物流。公司的主要产品是自产中成药、中药饮片、医药商业配送、大健康产品。公司曾荣获“国家级绿色工厂”、“CNAS实验室认证”、“全国文明单位”、ESG治理先锋等多项国家级荣誉。
发行价格：
10.03
{"stockData":{"symbol":"002864","market":"SZ","secType":"STK","nameCN":"盘龙药业","latestPrice":20.69,"timestamp":1785481434000,"preClose":20.25,"halted":0,"volume":2541121,"delay":0,"changeRate":0.0217,"floatShares":98596700,"shares":137000000,"eps":0.6349,"marketStatus":"已收盘","change":0.44,"latestTime":"07-31 15:00:00","open":20.11,"high":20.74,"low":20.1,"amount":52318700,"amplitude":0.0316,"askPrice":20.69,"askSize":178,"bidPrice":20.68,"bidSize":10,"shortable":0,"etf":0,"ttmEps":0.6349,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785720600000},"marketStatusCode":5,"adr":0,"adjPreClose":20.25,"symbolType":"stock","openAndCloseTimeList":[[1785461400000,1785468600000],[1785474000000,1785481200000]],"highLimit":22.28,"lowLimit":18.23,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":136700928,"isCdr":false,"pbRate":1.62,"roa":"--","peRate":32.587809,"roe":"1.28%","epsLYR":0.92,"committee":-0.636,"marketValue":2828000000,"turnoverRate":0.0258,"status":0,"floatMarketCap":2040000000},"requestUrl":"/m/hq/s/002864","defaultTab":"news","newsList":[{"id":"2651412594","title":"数十家机构扎堆调研！盘龙药业基药红利释放打开成长空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2651412594","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651412594?lang=zh_cn&edition=full","pubTime":"2026-07-16 16:00","pubTimestamp":1784188801,"startTime":"0","endTime":"0","summary":"在调研活动中，盘龙药业透露了阶段性发展目标。盘龙药业表示，目前公司销售团队全面覆盖三大终端市场，团队战斗力、专业程度可匹配基药落地后的放量节奏。机构普遍认为，人口老龄化持续拉动骨科慢病用药需求增长，骨科中成药赛道长期增量明确，盘龙药业有望持续受益。除此以外，盘龙药业“内生增长+外延发展”双轮驱动战略进一步打开长期想象空间。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202607/16/20260716517422.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202607/16/20260716517422.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260716/32309418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651552461","title":"盘龙药业（002864）披露2025年年度权益分派实施公告，7月15日股价上涨2.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651552461","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651552461?lang=zh_cn&edition=full","pubTime":"2026-07-15 22:22","pubTimestamp":1784125333,"startTime":"0","endTime":"0","summary":"截至2026年7月15日收盘，盘龙药业报收于30.65元，较前一交易日上涨2.58%，最新总市值为32.23亿元。该股当日开盘29.31元，最高30.96元，最低29.18元，成交额达2.27亿元，换手率为10.15%。近日，盘龙药业发布《2025年年度权益分派实施公告》。公告显示，公司2025年年度权益分派方案已获2026年5月26日召开的年度股东会审议通过。分红后公司总股本增至136,700,928股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500044918.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651010437","title":"盘龙药业（002864）披露控股股东持股比例因回购注销被动增加触及1%及5%整数倍公告，7月14日股价上涨2.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651010437","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651010437?lang=zh_cn&edition=full","pubTime":"2026-07-14 22:16","pubTimestamp":1784038582,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，盘龙药业报收于29.88元，较前一交易日上涨2.57%，最新总市值为31.76亿元。该股当日开盘28.74元，最高29.88元，最低28.07元，成交额达2.02亿元，换手率为9.45%。近日，盘龙药业发布《关于控股股东、实际控制人持股比例因公司回购注销被动增加触及1%及5%整数倍的公告》。公告显示，陕西盘龙药业集团股份有限公司于2026年7月13日完成2022年限制性股票回购注销，总股本由106,280,960股减少至105,154,560股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400049460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650590407","title":"盘龙药业：盘龙七片入选2026国家基药目录，凭硬核资质打开业绩增量空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2650590407","media":"中金财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650590407?lang=zh_cn&edition=full","pubTime":"2026-07-10 13:40","pubTimestamp":1783662002,"startTime":"0","endTime":"0","summary":"在此之前，盘龙七片已稳居医保甲类目录、斩获十余项国家级诊疗指南权威推荐，本次入围国家基本药物目录，是产品综合实力的再一次重磅升级。权威资质再次升级要了解盘龙七片此次入选的意义，首先要知道国家基本药物目录是什么。盘龙七片的热销来源于我国广泛的骨科慢病患者基数。这意味着，盘龙七片此次入选国家基本药物目录，将直接为其打开院外市场空间，实现院内院外用药场景的全面打通。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202607/10/20260710164482.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202607/10/20260710164482.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260710/32304048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645888742","title":"创新药概念震荡拉升，盘龙药业一度涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645888742","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645888742?lang=zh_cn&edition=full","pubTime":"2026-06-23 14:14","pubTimestamp":1782195288,"startTime":"0","endTime":"0","summary":"6月23日，创新药概念震荡拉升，盘龙药业一度大涨超9%。公司层面，盘龙药业是集药材规范化种植、药品生产、研发、销售为一体的现代化高新技术企业，以医药制造为核心主营业务，产业链涵盖现代中药、医药商业和大健康。长城证券指出，盘龙药业作为风湿骨科类中药龙头企业，将持续受益政策红利、人口老龄化趋势加速和消费升级趋势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026062300019848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159992","002864","BK1161","BK0239","06978","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640139113","title":"盘龙药业：截至2026年一季度公司已完成509个中药配方颗粒品种备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2640139113","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640139113?lang=zh_cn&edition=full","pubTime":"2026-06-04 11:34","pubTimestamp":1780544064,"startTime":"0","endTime":"0","summary":"证券之星消息，盘龙药业06月03日在投资者关系平台上答复投资者关心的问题。截至2026年一季度公司已完成509个中药配方颗粒品种备案，智能化产线已全面建成投产，具备全品种量产能力，同步组建了专项业务中心，依托现有覆盖全国的成熟营销网络，公司正积极推进全国各省份的挂网准入工作。后续公司也将持续根据行业政策、市场变化动态优化经营策略，稳步推进中药配方颗粒业务落地。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400014399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640495861","title":"盘龙药业（002864）披露向2026年股票期权激励计划激励对象授予股票期权的公告，6月1日股价上涨1.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640495861","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640495861?lang=zh_cn&edition=full","pubTime":"2026-06-01 18:03","pubTimestamp":1780308189,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，盘龙药业报收于29.33元，较前一交易日上涨1.91%，最新总市值为31.17亿元。公司于近日披露《关于向2026年股票期权激励计划激励对象授予股票期权的公告》。公告显示，陕西盘龙药业集团股份有限公司于2026年5月29日召开董事会，确定当日为股票期权授予日，向60名激励对象授予37.35万份股票期权，行权价格为31.11元/份。本次授予符合公司股权激励计划规定条件，不会导致股权分布不符合上市条件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100028562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638850542","title":"盘龙药业（002864）披露2026年股票期权激励计划内幕信息知情人及激励对象买卖公司股票情况自查报告，5月27日股价下跌0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638850542","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638850542?lang=zh_cn&edition=full","pubTime":"2026-05-27 17:36","pubTimestamp":1779874617,"startTime":"0","endTime":"0","summary":"截至2026年5月27日收盘，盘龙药业报收于28.45元，较前一交易日下跌0.39%，最新总市值为30.24亿元。该股当日开盘28.55元，最高28.72元，最低28.0元，成交额达4864.33万元，换手率为2.33%。盘龙药业于近日披露《关于公司2026年股票期权激励计划内幕信息知情人及激励对象买卖公司股票情况的自查报告》。公司未发现内幕信息泄露或利用内幕信息进行交易的情形。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700034733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635430783","title":"盘龙药业（002864）披露2026年股票期权激励计划（草案），5月13日股价上涨2.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635430783","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635430783?lang=zh_cn&edition=full","pubTime":"2026-05-13 18:29","pubTimestamp":1778668186,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，盘龙药业报收于31.61元，较前一交易日上涨2.96%，最新总市值为33.6亿元。该股当日开盘31.31元，最高32.05元，最低31.27元，成交额达1.3亿元，换手率为5.58%。近日，盘龙药业披露《2026年股票期权激励计划（草案）》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300034608.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633275186","title":"盘龙药业（002864）披露召开2025年年度股东会的通知，5月6日股价上涨0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633275186","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633275186?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:12","pubTimestamp":1778062323,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，盘龙药业报收于30.3元，较前一交易日上涨0.2%，最新总市值为32.2亿元。该股当日开盘30.38元，最高30.43元，最低30.1元，成交额达5557.01万元，换手率为2.49%。公司于近日披露《关于召开2025年年度股东会的通知》。公告显示，陕西盘龙药业集团股份有限公司将于2026年5月26日召开2025年年度股东会，会议由董事会召集，现场会议地点为西安市灞桥区现代纺织产业园灞柳二路2801号公司二楼会议室。股权登记日为2026年5月19日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600029414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632608350","title":"每周股票复盘：盘龙药业（002864）一季度净利降30.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632608350","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632608350?lang=zh_cn&edition=full","pubTime":"2026-05-03 07:57","pubTimestamp":1777766227,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，盘龙药业报收于30.24元，较上周的30.19元上涨0.17%。本周，盘龙药业4月30日盘中最高价报30.5元。本周关注点来自业绩披露要点：盘龙药业2026年一季报显示，归母净利润同比下降30.36%。股本股东变化截至2026年3月31日，盘龙药业股东户数为2.2万户，较2025年12月31日减少1890户，减幅7.91%。公司公告汇总公司2026年第一季度营业收入为222,541,696.37元，同比下降11.06%；归母净利润为21,760,948.70元，同比下降30.36%；扣非净利润为20,014,169.48元，同比下降30.39%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630039073","title":"盘龙药业（002864）披露2026年一季度报告，4月27日股价上涨0.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630039073","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630039073?lang=zh_cn&edition=full","pubTime":"2026-04-27 22:29","pubTimestamp":1777300174,"startTime":"0","endTime":"0","summary":"截至2026年4月27日收盘，盘龙药业报收于30.33元，较前一交易日上涨0.46%，最新总市值为32.24亿元。该股当日开盘30.24元，最高30.42元，最低29.72元，成交额达7362.07万元，换手率为3.32%。近日，陕西盘龙药业集团股份有限公司披露2026年第一季度报告。报告显示，本报告期营业收入为222,541,696.37元，较上年同期下降11.06%；归属于上市公司股东的净利润为21,760,948.70元，同比下降30.36%；归属于上市公司股东的扣除非经常性损益的净利润为20,014,169.48元，同比下降30.39%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700046763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629834106","title":"盘龙药业：坚持以高质量经营夯实基本面","url":"https://stock-news.laohu8.com/highlight/detail?id=2629834106","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629834106?lang=zh_cn&edition=full","pubTime":"2026-04-23 20:52","pubTimestamp":1776948728,"startTime":"0","endTime":"0","summary":"证券之星消息，盘龙药业04月22日在投资者关系平台上答复投资者关心的问题。坚持以高质量经营夯实基本面，常态化开展投资者沟通，严格执行持续稳定分红政策，积极传递公司长期价值。公司严格遵守信息披露相关法律法规及监管要求，不存在应披露而未披露的重大事项，所有重大信息均及时、公平、合规履行披露义务。相关项目进展公司将严格按照规定及时公告，请以官方披露信息为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300059146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624571232","title":"盘龙药业：公司高度重视股东回报与价值维护","url":"https://stock-news.laohu8.com/highlight/detail?id=2624571232","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624571232?lang=zh_cn&edition=full","pubTime":"2026-04-02 16:36","pubTimestamp":1775118982,"startTime":"0","endTime":"0","summary":"证券之星消息，盘龙药业(002864)04月02日在投资者关系平台上答复投资者关心的问题。投资者提问：公司股价低迷，10年前差不多就是这价位，跟经营业绩持续增长不匹配，处于低估状态，公司账上现金充足，建议董事会为股东着想，拿出3–4亿元回购注销公司股份？盘龙药业回复：尊敬的投资者您好！感谢您的关注和宝贵建议。公司高度重视股东回报与价值维护，资金统筹安排将兼顾主业经营、研发创新与长期发展，持续夯实内在价值。公司将严格依规履行审议程序及信息披露义务。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200027208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621295086","title":"股市必读：盘龙药业（002864）3月23日收盘跌7.82%，主力净流入734.79万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621295086","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621295086?lang=zh_cn&edition=full","pubTime":"2026-03-24 02:57","pubTimestamp":1774292228,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，盘龙药业报收于31.34元，下跌7.82%，换手率8.07%，成交量5.99万手，成交额1.92亿元。交易信息汇总股价提醒3月23日盘龙药业收盘报31.34元，跌7.82%，当日成交598.54万元。前10个交易日资金流向情况：主力资金累计净流入1130.12万元，股价累计下跌7.5%。资金流向3月23日主力资金净流入734.79万元；游资资金净流出1563.32万元；散户资金净流入828.53万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400002642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619199639","title":"盘龙药业：3月12日董事朱文锋减持股份合计2.25万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2619199639","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619199639?lang=zh_cn&edition=full","pubTime":"2026-03-13 19:01","pubTimestamp":1773399674,"startTime":"0","endTime":"0","summary":"证券之星消息，根据3月13日市场公开信息、上市公司公告及交易所披露数据整理，盘龙药业（002864）最新董监高及相关人员股份变动情况：2026年3月12日公司董事朱文锋共减持公司股份2.25万股，占公司总股本为0.0212%。变动期间公司股价下跌1.91%，3月12日当日收盘报33.3元。盘龙药业近半年内的董监高及核心技术人员增减持详情如下：盘龙药业的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300033464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616346888","title":"盘龙药业最新公告：获得硫酸氨基葡萄糖胶囊药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2616346888","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616346888?lang=zh_cn&edition=full","pubTime":"2026-03-03 18:19","pubTimestamp":1772533197,"startTime":"0","endTime":"0","summary":"盘龙药业公告称，公司收到国家药品监督管理局颁发的硫酸氨基葡萄糖胶囊的《药品注册证书》。根据米内网数据显示，2024年国内城市和县级公立医院、城市和网上药店、城市社区医院和乡镇卫生院的销售金额约33.62亿元人民币。本次获批将进一步丰富公司非处方药管线与骨科慢病产品矩阵，有利于公司拓展院外市场、推进渠道终端下沉，提升品牌在基层及零售终端的影响力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300033639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614703759","title":"股市必读：盘龙药业（002864）2月25日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2614703759","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614703759?lang=zh_cn&edition=full","pubTime":"2026-02-26 01:47","pubTimestamp":1772041632,"startTime":"0","endTime":"0","summary":"截至2026年2月25日收盘，盘龙药业报收于37.61元，下跌0.66%，换手率4.95%，成交量3.67万手，成交额1.38亿元。董秘最新回复投资者： 公司对腰间盘突出，脊椎骨3，4，5节压迫神经，从而导致人体站不直，神经痛，走路难＇痛的问题？公司深耕主业，已形成包括药品研发、生产及销售在内的完整业务体系。相关产品主要依据获批适应症用于相应病症的治疗。当日关注点来自交易信息汇总：2月25日主力资金净流出326.48万元，散户资金净流入262.32万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600000965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609309344","title":"盘龙药业（002864）披露注销部分募集资金账户公告，2月5日股价上涨3.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609309344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609309344?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:17","pubTimestamp":1770301035,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘，盘龙药业报收于36.46元，较前一交易日上涨3.05%，最新总市值为38.75亿元。该股当日开盘35.41元，最高36.9元，最低35.23元，成交额达2.69亿元，换手率为9.99%。近日，陕西盘龙药业集团股份有限公司发布《关于注销部分募集资金账户的公告》。公司称已按规定履行信息披露义务，确保内容真实、准确、完整。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608316877","title":"盘龙药业（002864）披露董事减持股份预披露公告，2月3日股价上涨0.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608316877","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608316877?lang=zh_cn&edition=full","pubTime":"2026-02-03 22:25","pubTimestamp":1770128723,"startTime":"0","endTime":"0","summary":"截至2026年2月3日收盘，盘龙药业报收于35.35元，较前一交易日上涨0.28%，最新总市值为37.57亿元。近日，盘龙药业发布《关于董事减持股份预披露公告》。其计划在公告披露之日起15个交易日后的3个月内，通过集中竞价方式减持不超过22,500股，占剔除公司已回购股份的总股本比例不超过0.0212%。减持期间为2026年3月5日至2026年6月4日，减持价格将按市场价格确定。本次减持符合其在任职期间的相关承诺，不存在违反承诺的情形。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300043224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1785495211001,"stockEarnings":[{"period":"1week","weight":-0.0581},{"period":"1month","weight":0.0294},{"period":"3month","weight":-0.1217},{"period":"6month","weight":-0.2633},{"period":"1year","weight":-0.1348},{"period":"ytd","weight":-0.1388}],"compareEarnings":[{"period":"1week","weight":-0.0186},{"period":"1month","weight":-0.0708},{"period":"3month","weight":-0.0748},{"period":"6month","weight":-0.0761},{"period":"1year","weight":0.0523},{"period":"ytd","weight":-0.0414}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"陕西盘龙药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"22008人(较上一季度减少7.91%)","perCapita":"4480股","listingDate":"2017-11-16","address":"陕西省商洛市柞水县盘龙生态产业园","registeredCapital":"13670万元","survey":" 陕西盘龙药业集团股份有限公司的主营业务是药材规范化种植、药品生产、研发、销售和医药物流。公司的主要产品是自产中成药、中药饮片、医药商业配送、大健康产品。公司曾荣获“国家级绿色工厂”、“CNAS实验室认证”、“全国文明单位”、ESG治理先锋等多项国家级荣誉。","listedPrice":10.03},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"盘龙药业(002864)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供盘龙药业(002864)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"盘龙药业,002864,盘龙药业股票,盘龙药业股票老虎,盘龙药业股票老虎国际,盘龙药业行情,盘龙药业股票行情,盘龙药业股价,盘龙药业股市,盘龙药业股票价格,盘龙药业股票交易,盘龙药业股票购买,盘龙药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"盘龙药业(002864)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供盘龙药业(002864)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}